LegoChem Brings Late Christmas Cheer With $1.7bn ADC Deal
Janssen Gets Worldwide Rights To Trop2-Directed ADC
LegoChem Biosciences has sealed yet another sizable out-licensing agreement with a global big pharma firm, this time with Janssen, underlining the continued keen global interest in ADCs.
